Skip to content
Open access

SENP7 mediates deSUMOylation and deubiquitination of SP1 to promote lung adenocarcinoma progression and chemoresistance

Sep 2026 · Translational Oncology · Vol 72 · 0 citations · 39 references
Medicine

Abstract

Highlights • SENP7 protein is markedly expressed in LUAD, with a strong correlation to disease progression and adverse patient prognoses.• The depletion of SENP7 substantially impedes LUAD progression in both in vitro and in vivo.• SP1 is a bona fide target of SENP7, with SENP7-mediated deSUMOylation, deubiquitination, and stabilization of SP1 being essential for LUAD development and chemoresistance.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.